An Observational Study on the Impact of Menstrual Cycle Phases on Carbohydrate Intake, Insulin Delivery and Glycaemia in Women With Type 1 Diabetes Using MiniMed 780G Automated Insulin Delivery System.

IF 6.1 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Diabetes, Obesity & Metabolism Pub Date : 2026-11-01 Epub Date: 2026-08-17 DOI:10.1111/dom.71234
Suresh Rama Chandran, Wei Mian Ang, Gek Hsiang Lim, Gerald Gui Ren Sng, Daphne Gardner
{"title":"An Observational Study on the Impact of Menstrual Cycle Phases on Carbohydrate Intake, Insulin Delivery and Glycaemia in Women With Type 1 Diabetes Using MiniMed 780G Automated Insulin Delivery System.","authors":"Suresh Rama Chandran, Wei Mian Ang, Gek Hsiang Lim, Gerald Gui Ren Sng, Daphne Gardner","doi":"10.1111/dom.71234","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To quantify changes in carbohydrate intake, insulin delivery and glycaemia across menstrual cycle phases in women with type 1 diabetes using the MiniMed 780G automated insulin delivery system (MM780G).</p><p><strong>Materials and methods: </strong>Women on MM780G provided menstrual cycle data. Continuous glucose monitoring and insulin delivery data were retrieved from the CareLink portal. Daily values for time in range (TIR, 3.9-10 mmol/L), total carbohydrates, total basal, total bolus and total insulin were calculated. Menstrual phases were classified using two methods: Method 1 compared the pre-menses week with the menses week; Method 2 compared five physiological phases with mid-follicular as reference. Linear mixed-effects models with random intercepts for participant and cycle were fitted.</p><p><strong>Results: </strong>Fifteen women (mean age 35.9 years, BMI 23.3 kg/m<sup>2</sup>, HbA1c 50.8 mmol/mol [6.8%]) contributed 118 cycles. In the pre-menses week, carbohydrate intake (β = +0.164 g kg<sup>-1</sup>, adjusted p = 0.003), total daily bolus (β = +0.018 U kg<sup>-1</sup>, adjusted p = 0.001), total daily basal (β = +0.011 U kg<sup>-1</sup>, adjusted p = 0.003) and total daily dose (β = +0.029 U kg<sup>-1</sup>, adjusted p < 0.001) were significantly higher than the menses week, yet TIR was lower (β = -3.487 percentage points, adjusted p < 0.001). In Method 2, total daily basal and total daily dose were significantly higher in the late luteal phase, and TIR was lower in the mid luteal phase (β = -3.34 percentage points, adjusted p = 0.007).</p><p><strong>Conclusions: </strong>Menstrual cycle phase is associated with significant changes in carbohydrate intake, insulin delivery and TIR in women using MiniMed 780G. Despite increased insulin delivery, TIR was lower in the luteal phase, suggesting partial adaptation to menstrual cycle-related physiological changes.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":"10173-10182"},"PeriodicalIF":6.1000,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.71234","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/17 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: To quantify changes in carbohydrate intake, insulin delivery and glycaemia across menstrual cycle phases in women with type 1 diabetes using the MiniMed 780G automated insulin delivery system (MM780G).

Materials and methods: Women on MM780G provided menstrual cycle data. Continuous glucose monitoring and insulin delivery data were retrieved from the CareLink portal. Daily values for time in range (TIR, 3.9-10 mmol/L), total carbohydrates, total basal, total bolus and total insulin were calculated. Menstrual phases were classified using two methods: Method 1 compared the pre-menses week with the menses week; Method 2 compared five physiological phases with mid-follicular as reference. Linear mixed-effects models with random intercepts for participant and cycle were fitted.

Results: Fifteen women (mean age 35.9 years, BMI 23.3 kg/m2, HbA1c 50.8 mmol/mol [6.8%]) contributed 118 cycles. In the pre-menses week, carbohydrate intake (β = +0.164 g kg-1, adjusted p = 0.003), total daily bolus (β = +0.018 U kg-1, adjusted p = 0.001), total daily basal (β = +0.011 U kg-1, adjusted p = 0.003) and total daily dose (β = +0.029 U kg-1, adjusted p < 0.001) were significantly higher than the menses week, yet TIR was lower (β = -3.487 percentage points, adjusted p < 0.001). In Method 2, total daily basal and total daily dose were significantly higher in the late luteal phase, and TIR was lower in the mid luteal phase (β = -3.34 percentage points, adjusted p = 0.007).

Conclusions: Menstrual cycle phase is associated with significant changes in carbohydrate intake, insulin delivery and TIR in women using MiniMed 780G. Despite increased insulin delivery, TIR was lower in the luteal phase, suggesting partial adaptation to menstrual cycle-related physiological changes.

使用MiniMed 780G自动胰岛素输送系统研究月经周期阶段对1型糖尿病女性碳水化合物摄入、胰岛素输送和血糖的影响
目的:使用MiniMed 780G自动胰岛素输送系统(MM780G)量化1型糖尿病女性月经周期中碳水化合物摄入量、胰岛素输送和血糖的变化。材料和方法:使用MM780G的女性提供月经周期数据。从CareLink门户网站检索连续血糖监测和胰岛素递送数据。计算时间范围(TIR, 3.9-10 mmol/L)、总碳水化合物、总基础、总剂量和总胰岛素的每日数值。采用两种方法对月经周期进行分类:方法一将经前周与经中周进行比较;方法2以中卵泡为对照,比较5个生理相。拟合了参与者和周期随机截距的线性混合效应模型。结果:15名女性(平均年龄35.9岁,BMI 23.3 kg/m2, HbA1c 50.8 mmol/mol[6.8%])参与了118个周期。在经前一周,碳水化合物摄入量(β = +0.164 g kg-1,调整p = 0.003)、总日剂量(β = +0.018 U kg-1,调整p = 0.001)、总日基础(β = +0.011 U kg-1,调整p = 0.003)和总日剂量(β = +0.029 U kg-1,调整p)与使用MiniMed 780G的女性碳水化合物摄入量、胰岛素释放和TIR的显著变化相关。尽管胰岛素释放量增加,但黄体期的TIR较低,提示部分适应了月经周期相关的生理变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书